stockrowGSK PLC Sponsored ADR
GSK Healthcare Drug Manufacturers General
GSK PLC Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $43.1 billion, up 7.44% from fiscal 2024.
- Revenue
- +3.75%
- EPS
- −14.7%
- Free cash flow
- +62.4%
- Total debt
- +33.2%
Quarter to September 2026, against a year earlier
Follow GSK
Alert me
GSK PLC Sponsored ADR (GSK) Operating margin
GSK PLC Sponsored ADR's operating margin over the twelve months to 30 September 2026 was 18.0%, down 6.3 percentage points from fiscal 2025 (24.3%). Over the past ten years it has ranged from 9.32% (fiscal 2016) to 43.2% (fiscal 2015); the current reading is higher than 91% of that period. That is in line with the Drug Manufacturers General industry median of 18.3% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | 24.3% | 11.46 |
| FY2024 | 12.8% | (9.42) |
| FY2023 | 22.2% | 0.30 |
| FY2022 | 21.9% | 3.76 |
| FY2021 | 18.2% | (4.64) |
| FY2020 | 22.8% | 2.20 |
| FY2019 | 20.6% | 2.83 |
| FY2018 | 17.8% | 4.25 |
| FY2017 | 13.5% | 4.22 |
| FY2016 | 9.32% | (33.83) |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | 23.9% | 18.21 |
| Jun 2026 | 5.72% | (24.34) |
| Mar 2026 | 30.1% | 17.18 |
| Dec 2025 | 12.9% | (17.46) |
| 43 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| NVO Novo Nordisk A/S compare | 43.4% |
| AMGN Amgen Inc. compare | 32.4% |
| AZN AstraZeneca PLC compare | 23.7% |
| BMY Bristol Myers Squibb Company compare | 22.7% |
| PFE Pfizer Inc. compare | 21.4% |
| SNY Sanofi compare | 18.7% |
| GSK GSK PLC Sponsored ADR | 18.0% |
| BIIB Biogen Inc. compare | 7.53% |
| GILD Gilead Sciences, Inc. compare | −7.63% |
| Drug Manufacturers General industry median | 18.3% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on GSK
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement